Alcoholic liver disease: pathologic, pathogenetic and clinical aspects.

Area of Science:

• Hepatology
• Toxicology
• Gastroenterology

Background:

• Alcoholic liver disease (ALD) encompasses a spectrum of conditions including steatosis, alcoholic hepatitis, and cirrhosis.
• Genetic liver diseases like hemochromatosis and porphyria cutanea tarda may show associations with alcohol intake.
• Alcohol's role in chronic hepatitis is debated, potentially reflecting co-existing hepatitis C infection.

Purpose of the Study:

• To outline the pathological spectrum of alcoholic liver injury.
• To describe the histological features and progression of ALD.
• To discuss the clinical manifestations and underlying mechanisms of alcohol-induced liver damage.

Main Methods:

• Histopathological examination of liver biopsies.
• Review of clinical presentations and laboratory findings in patients with ALD.
• Analysis of the pathogenetic mechanisms involving ethanol metabolism and acetaldehyde toxicity.

Main Results:

• Steatosis (fatty liver) is a primary consequence, typically macrovesicular.
• Alcoholic hepatitis (steatonecrosis) is characterized by steatosis, Mallory bodies, and pericellular fibrosis, predominantly in zone 3.
• Cirrhosis develops from progressive fibrosis, leading to portal hypertension and potential hepatocellular carcinoma (5-15% of cases).

Conclusions:

• ALD results from ethanol metabolism, acetaldehyde toxicity, and immune responses, potentially exacerbated by viral hepatitis.
• Clinical manifestations vary with disease stage: steatosis (extrahepatic), hepatitis (parenchymal insufficiency), and cirrhosis (portal hypertension).
• Alcohol potentiates the hepatotoxicity of other agents, such as acetaminophen, highlighting a critical aspect of its liver injury.